Sign in

Filings

Finds words inside filing documents. Searching Merck & Co., Inc.'s filings · 31 documents indexed.

9 documents · 13 matches

  1. MRK Merck & Co., Inc. 10-Q 2025-11-05

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariffs on certain foreign imports into the U.S. The impact of the tariffs on Merck’s business depends on a number
    2 matches in this document

  2. MRK Merck & Co., Inc. 10-Q 2025-08-05

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariffs on certain foreign imports into the U.S. The impact of the tariffs on Merck’s business depends on a number
    2 matches in this document

  3. MRK Merck & Co., Inc. 10-Q 2026-11-04

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    Section 232 tariffs for three years, enabling the Company to make investments in the U.S. to reshore manufacturing for American patients.
    1 match in this document

  4. MRK Merck & Co., Inc. 10-Q 2026-08-07

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    Section 232 tariffs for three years, enabling the Company to make investments in the U.S. to reshore manufacturing for American patients.
    1 match in this document

  5. MRK Merck & Co., Inc. 10-Q 2026-05-04

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    Section 232 tariffs for three years, enabling the Company to make investments in the U.S. to reshore manufacturing for American patients.
    1 match in this document

  6. MRK Merck & Co., Inc. 10-K 2026-02-24

    Item 1. Business.

    Section 232 tariffs for three years, enabling the Company to make investments in the U.S. to reshore manufacturing for American patients.
    3 matches in this document

  7. MRK Merck & Co., Inc. 8-K 2026-02-03

    tariffs for three years, enabling the Company to make investments in the U.S. to reshore manufacturing for American patients. The Company
    1 match in this document

  8. MRK Merck & Co., Inc. 8-K 2025-10-30

    tariffs, partially offset by an estimated negative impact related to the acquisition of Verona Pharma and an incremental negative impact
    1 match in this document

  9. MRK Merck & Co., Inc. 8-K 2025-07-29

    Company’s financial outlook related to the impact of tariffs is unchanged pending the outcome of additional potential government actions.
    1 match in this document

Page 1 of 1 · 9 documents